AB

Alcide Barberis

EU Esbatech, An Alcon Biomedical Research Unit: 9 patents #3 of 16Top 20%
ES Esbatech: 4 patents #1 of 5Top 20%
TS Telormedix Sa: 4 patents #3 of 6Top 50%
DA Delenex Therapeutics Ag: 2 patents #2 of 11Top 20%
CA Cell Medica Switzerland Ag: 1 patents #6 of 9Top 70%
NA Novartis Ag: 1 patents #2,882 of 5,128Top 60%
UP Urogen Pharma: 1 patents #16 of 24Top 70%
Overall (All Time): #195,081 of 4,157,543Top 5%
22
Patents All Time

Issued Patents All Time

Showing 1–22 of 22 patents

Patent #TitleCo-InventorsDate
10570190 Immunoglobulin frameworks which demonstrate enhanced stability in the intracellular environment and methods of identifying same Kathrin Tissot, Stefan Ewert, Adrian Auf Der Maur, Dominik Escher 2020-02-25
10125186 Immunoglobulin frameworks which demonstrate enhanced stability in the intracellular environment and methods of identifying same Kathrin Tissot, Stefan Ewert, Adrian Auf Der Maur, Dominik Escher 2018-11-13
9683034 Stable and soluble antibodies inhibiting TNFα Stefan Ewert, David Urech, Adrian Auf Der Maur, Peter Lichtlen 2017-06-20
9540407 Phospholipid drug analogs Roberto Maj, Franco Pattarino, Emanuela Mura 2017-01-10
9518108 Immunoglobulin frameworks which demonstrate enhanced stability in the intracellular environment and methods of identifying same Kathrin Tissot, Stefan Ewert, Adrian Auf Der Maur, Dominik Escher 2016-12-13
9512411 Nucleic acid encoding antibodies binding to the extracellular domain of the receptor tyrosine kinase ALK Adrian Auf Der Maur, Peter Lichtlen 2016-12-06
9315572 Stable and soluble antibodies inhibiting TNF alpha Stefan Ewert, David Urech, Adrian Auf Der Maur, Peter Lichtlen 2016-04-19
9180183 Phospholipid drug analogs Roberto Maj, Franco Pattarino, Emanuela Mura 2015-11-10
9173936 Phospholipid drug analogs Roberto Maj, Franco Pattarino, Emanuela Mura 2015-11-03
9173935 Phospholipid drug analogs Roberto Maj, Franco Pattarino, Emanuela Mura 2015-11-03
9050319 Phospholipid drug analogs Roberto Maj, Franco Pattarino, Emanuela Mura 2015-06-09
8945563 Method for treating glioblastoma using antibodies binding to the extracellular domain of the receptor tyrosine kinase ALK Adrian Auf Der Maur, Peter Lichtlen 2015-02-03
8936785 scFv antibodies which pass epithelial and/or endothelial layers Adrian Auf Der Maur, David Urech, Peter Lichtlen 2015-01-20
8853362 Immunoglobulin frameworks which demonstrate enhanced stability in the intracellular environment and methods of identifying same Kathrin Tissot, Stefan Ewert, Adrian Auf Der Maur, Dominik Escher 2014-10-07
8691228 Stable and soluble antibodies inhibiting TNFα Stefan Ewert, David Urech, Adrian Auf Der Maur, Peter Lichtlen 2014-04-08
8389693 Stable and soluble antibodies inhibiting TNFα Stefan Ewert, David Urech, Adrian Auf Der Maur, Peter Lichtlen 2013-03-05
8067547 Stable and soluble antibodies inhibiting TNFα Stefan Ewert, David Urech, Adrian Auf Der Maur, Peter Lichtlen 2011-11-29
7902340 Antibodies binding to the extracellular domain of the receptor tyrosine kinase ALK Adrian Auf Der Maur, Peter Lichtlen 2011-03-08
7566528 Method for the identification and/or validation of receptor tyrosine kinase inhibitors Tea Gunde, Catherine Berset 2009-07-28
7258985 Intrabodies with defined framework that is stable in a reducing environment and applications thereof Adrian Auf Der Maur, Dominik Escher 2007-08-21
7258986 Intrabodies with defined framework that is stable in a reducing environment and applications thereof Adrian Auf Der Maur, Dominik Escher 2007-08-21
6821728 Screening system Dominik Escher 2004-11-23